Home » 2019 » August » 15

Bio-Thera Solutions begins phase 1 trial for Simponi biosimilar BAT2506

Bio-Thera Solutions begins phase 1 trial for Simponi biosimilar BAT2506

Chinese biotech company Bio-Thera Solutions has started dosing in a phase 1 clinical trial to study the pharmacokinetics and safety of BAT2506, a proposed biosimilar of Janssen Biotech’s Simponi (golimumab). The early-stage clinical study is a randomized two-arm, parallel-group trial that will have nearly 182 healthy volunteers. Each of the patients will be subjected to […]

The post Bio-Thera Solutions begins phase 1 trial for Simponi biosimilar BAT2506 appeared first on PharmaNewsDaily.com.

Neuropore gets FDA orphan drug designation for NPT520-34 for ALS

Neuropore gets FDA orphan drug designation for NPT520-34 for ALS

Neuropore Therapies has secured orphan drug designation for NPT520-34 from the US Food and Drug Administration (FDA) for the treatment of amyotrophic lateral sclerosis (ALS). The California-based biopharma company said that the orphan drug designation will enable the development of NPT520-34 in the treatment of the debilitating medical condition for which there are not many […]

The post Neuropore gets FDA orphan drug designation for NPT520-34 for ALS appeared first on PharmaNewsDaily.com.

Z Natural Foods introduces Berry Punch Collagen Peptides Powder

Z Natural Foods introduces Berry Punch Collagen Peptides Powder

Florida-based Z Natural Foods has launched its new Berry Punch Collagen Peptides Powder, which is claimed to be high in protein, vitamins and minerals and more antioxidants than green tea or red wine, as per the food product launch news. The food powder comprises phytochemical-dense superfruits and berries combined with high protein collagen peptides. Containing […]

BASF and TU Berlin to advance artificial intelligence through BASLEARN

BASF and TU Berlin to advance artificial intelligence through BASLEARN

German chemical producer BASF and Technische Universität Berlin (TU Berlin) have partnered to cooperate in the area of machine learning through the Joint Lab for Machine Learning (BASLEARN) to be based in Berlin, Germany. BASLEARN will focus on developing workable new mathematical models and algorithms for fundamental questions relating to chemistry in the coming years. […]

PAOLA 1 trial results : Lynparza, bevacizumab combo achieves PFS goal in phase 3 trial

PAOLA 1 trial results : Lynparza, bevacizumab combo achieves PFS goal in phase 3 trial

PAOLA 1 trial results : Lynparza (olaparib), a cancer drug which was jointly developed by AstraZeneca and MSD, in combination with bevacizumab, met the primary endpoint of the phase 3 PAOLA 1 clinical trial in patients with advanced ovarian cancer. The PAOLA 1 primary endpoint is the statistically-significant and clinically-meaningful improvement shown by Lynparza plus […]

The post PAOLA 1 trial results : Lynparza, bevacizumab combo achieves PFS goal in phase 3 trial appeared first on PharmaNewsDaily.com.

Domo Chemicals to acquire Solvay’s Performance Polyamides Business in Europe

Domo Chemicals to acquire Solvay’s Performance Polyamides Business in Europe

Belgian chemical company Solvay has agreed to sell its Performance Polyamides Business in Europe to Domo Chemicals for approximately €300 million as part of the European Commission’s merger control clearance process. The transaction also marks the divestment of Solvay’s remaining Polyamides business to BASF. The assets acquired by Domo Chemicals involve Solvay’s Engineering Plastics operations in […]

Tullow Oil makes maiden oil discovery in Orinduik block offshore Guyana

Tullow Oil makes maiden oil discovery in Orinduik block offshore Guyana

Orinduik block oil discovery : Tullow Oil and partners have made an oil discovery in the Orinduik block in the Suriname Guyana basin through the drilling of the Jethro-1 exploration well, as per the latest oil and gas industry news. The Jethro-1 well, which was drilled by the Stena Forth drillship to a total depth […]

TB Alliance bags Pretomanid FDA approval for highly drug-resistant TB

TB Alliance bags Pretomanid FDA approval for highly drug-resistant TB

Pretomanid FDA approval : Non-profit organization TB Alliance has secured approval for Pretomanid Tablets in combination with bedaquiline and linezolid from the US Food & Drug Administration (FDA) for the treatment of highly drug-resistant forms of tuberculosis. The combination regimen was approved by the FDA under the Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD […]

The post TB Alliance bags Pretomanid FDA approval for highly drug-resistant TB appeared first on PharmaNewsDaily.com.

US gene therapy company Renovacor raises $11m for BAG3 gene therapy

US gene therapy company Renovacor raises $11m for BAG3 gene therapy

US gene therapy company Renovacor, which is engaged in developing BAG3 gene therapy and other gene therapies for cardiovascular disease, has raised $11 million through a Series A financing round led jointly by Novartis Venture Fund, Broadview Ventures, and BioAdvance. New Leaf Venture Partners and Innogest Capital also joined the Series A funding round. The […]

The post US gene therapy company Renovacor raises $11m for BAG3 gene therapy appeared first on PharmaNewsDaily.com.

Dow to divest its acetone derivatives business to Altivia

Dow to divest its acetone derivatives business to Altivia

US commodity chemical company Dow has agreed to sell its acetone derivatives business to Altivia Ketones & Additives, an affiliate of Altivia Petrochemicals, for an undisclosed amount. In addition to the Institute Industrial Park, the sale involves Dow’s acetone derivatives business and associated chemical manufacturing assets at Institute, West Virginia, US. However, Dow with ownership […]


Notice: Undefined variable: additional_loop in /var/www/wp-content/themes/_connect/archive-default.php on line 10

Notice: Trying to get property of non-object in /var/www/wp-content/themes/_connect/archive-default.php on line 10
Page 1 of 212